Methimazole (Tapazole) Cost in Idaho: Prices, Insurance, and Savings for 2026

What Generic Methimazole Actually Costs at Idaho Pharmacies

The average cash price for generic methimazole at Idaho retail pharmacies in 2026 sits around $15 per month for a standard maintenance dose of 10 to 30 mg daily. That figure represents a sharp drop from the brand-name Tapazole list price of roughly $80 per month set by Pfizer.

Pricing varies by pharmacy. Large chains in Boise, Idaho Falls, and Nampa tend to cluster near the $12 to $18 range for a 30-day supply. Independent pharmacies may price higher or lower depending on their wholesale contracts. Costco and Walmart pharmacies in Idaho consistently rank among the cheapest options, sometimes falling below $10 for a 30-count supply of 10 mg tablets.

The generic version of methimazole is rated AB by the FDA, meaning it is considered therapeutically equivalent to the brand product 1. Generic penetration for methimazole exceeds 95% nationally, and Idaho follows the same pattern. Few prescribers write for brand-name Tapazole unless a patient has a documented intolerance to a specific generic formulation's inactive ingredients.

For patients on higher doses during the initial titration phase of Graves disease treatment (sometimes 30 to 40 mg daily), monthly costs scale accordingly. A 90-count supply of 10 mg tablets might run $30 to $45 cash, still well within reach for most patients compared to other chronic disease medications. Cooper et al. (2005) established methimazole as the preferred first-line antithyroid drug in the United States, reinforcing that affordable access matters given patients may require treatment for 12 to 18 months or longer 2.

Idaho Medicaid Does Not Cover Methimazole

Idaho Medicaid does not include methimazole on its preferred drug list as of 2026. This is a genuine coverage gap for low-income Idahoans with Graves disease or other forms of hyperthyroidism.

Patients enrolled in Idaho Medicaid who need antithyroid therapy face a few options. Propylthiouracil (PTU) may be covered under certain formulary provisions, though the American Thyroid Association (ATA) recommends methimazole over PTU for most non-pregnant adults due to PTU's higher risk of hepatotoxicity 3. That recommendation creates a clinical tension: the preferred drug is not the covered drug.

Idaho Medicaid does allow prior authorization requests. A prescribing physician can submit documentation showing medical necessity for methimazole over PTU, citing ATA guidelines and the patient's clinical profile. Approval is not guaranteed, and processing times vary. Some patients report waiting two to four weeks for a determination.

The practical workaround for many Idaho Medicaid patients is the cash price itself. At $15 per month, generic methimazole costs less than many insurance copays for covered drugs. Several Idaho endocrinologists have noted that the out-of-pocket cost is low enough that patients sometimes bypass the prior authorization process entirely and simply pay cash at the pharmacy counter. This is not an ideal systemic solution, but it reflects the reality of a $15-per-month medication.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans sold on the Idaho health exchange (Your Health Idaho) and most employer-sponsored plans cover generic methimazole. The drug sits on Tier 1 (preferred generic) of nearly every major commercial formulary.

Typical copays on commercial plans range from $0 to $15 for a 30-day supply. Blue Cross of Idaho, SelectHealth, PacificSource, and Mountain Health CO-OP all list generic methimazole as a preferred drug. Patients on high-deductible health plans (HDHPs) will pay the full cash price until meeting their deductible, but at $15 per month, the financial impact remains modest.

Medicare Part D plans cover methimazole consistently. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap that took full effect in 2025, methimazole costs for Medicare beneficiaries are effectively negligible. Even before reaching the cap, Part D copays for Tier 1 generics rarely exceed $10.

For brand-name Tapazole, insurance coverage is less predictable. Many plans require step therapy (try generic first) or impose non-preferred brand copays of $40 to $60. Pfizer offers a savings card for branded Tapazole that can reduce copays, though eligibility restrictions apply. The savings card typically does not work for patients on government-funded insurance programs including Medicare, Medicaid, and Tricare 1.

Compounded Methimazole Is Legal in Idaho Through 503A Pharmacies

Idaho permits compounding pharmacies licensed under Section 503A of the Federal Food, Drug, and Cosmetic Act to prepare methimazole formulations. This is relevant for two patient populations: those who need non-standard doses and those who cannot tolerate commercial tablet excipients.

A 503A pharmacy in Idaho can compound methimazole into capsules, suspensions, or transdermal preparations based on a valid patient-specific prescription. The FDA's compounding framework requires 503A pharmacies to compound in response to individual prescriptions rather than producing drugs in bulk for general distribution 4.

Compounded methimazole pricing in Idaho varies significantly by pharmacy and formulation. Some 503A pharmacies advertise compounded methimazole capsules at prices competitive with or below generic tablets. A transdermal gel formulation (sometimes used for cats, but occasionally prescribed for humans with swallowing difficulties) typically costs more due to the compounding complexity.

Idaho does not impose additional state-level restrictions on methimazole compounding beyond federal 503A requirements. The Idaho Board of Pharmacy oversees compounding pharmacy licensure and inspections. Patients seeking compounded methimazole should verify that their pharmacy holds a current Idaho compounding license and maintains compliance with USP 795 (non-sterile compounding) or USP 797 (sterile compounding) standards as applicable.

One caution: compounded drugs are not FDA-approved products and are not subject to the same bioequivalence testing as generic medications. The ATA and the Endocrine Society do not specifically recommend compounded methimazole when commercially manufactured tablets are available and tolerated 5.

Telehealth Prescribing Is Permitted in Idaho

Idaho allows licensed physicians and advanced practice providers to prescribe methimazole via telehealth. The state's telehealth parity law, updated through multiple legislative sessions, requires that providers hold an active Idaho medical license or participate in an interstate compact.

Thyroid function testing (TSH, free T4, free T3) still requires a blood draw at a local lab. Quest Diagnostics and Labcorp both operate draw sites across Idaho, including in smaller cities like Twin Falls, Pocatello, and Lewiston. After labs confirm hyperthyroidism, a telehealth provider can prescribe methimazole, set the starting dose, and schedule follow-up lab monitoring at 4- to 6-week intervals per ATA guidelines 3.

Telehealth appointments for thyroid management in Idaho typically cost $50 to $150 without insurance, depending on the platform. HealthRX and similar telehealth services can evaluate patients, order labs, and prescribe methimazole without requiring an in-person visit. This model is particularly valuable in rural Idaho, where endocrinology offices may be hours away. Idaho has only about 30 practicing endocrinologists for a population exceeding 2 million, concentrating most specialists in the Boise metropolitan area.

The Ryan Haight Act requires that controlled substances prescribed via telehealth follow specific DEA rules. Methimazole is not a controlled substance, so this restriction does not apply. Any Idaho-licensed provider with prescriptive authority can prescribe it after a telehealth evaluation.

Discount Programs and Savings Strategies

Several pathways exist for reducing methimazole costs below the already-low $15 average in Idaho.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare all offer coupons accepted at Idaho pharmacies. These can drop the price to $4 to $8 for a 30-day supply at participating chains. The coupons function as a cash-pay alternative and cannot be combined with insurance.

Pfizer savings card. For patients specifically prescribed brand-name Tapazole, Pfizer's savings program may reduce copays to as low as $0 for commercially insured patients. The card is not valid for government insurance beneficiaries. Patients can check eligibility through Pfizer's patient assistance website or ask their pharmacy 1.

$4 generic lists. Some Idaho Walmart and Kroger (Fred Meyer) locations include methimazole on their $4 generic lists for a 30-day supply. Availability can change, so patients should confirm with their local pharmacy before assuming the $4 price applies.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of assistance programs for methimazole. Patients at or below 200% of the federal poverty level who lack insurance coverage may qualify for free medication through manufacturer or nonprofit programs.

90-day fills. Mail-order pharmacies and some Idaho retail pharmacies offer 90-day supplies at a reduced per-unit cost. A 90-day supply of generic methimazole through a mail-order pharmacy might run $20 to $35 total, compared to $45 for three separate 30-day fills at retail.

Dr. David Cooper, who authored the landmark 2005 New England Journal of Medicine review establishing methimazole's superiority over PTU as first-line therapy, noted: "The clinical advantages of methimazole, its once-daily dosing, its superior safety profile, and its lower cost relative to radioactive iodine make it the preferred initial treatment for Graves hyperthyroidism in most patients" 2.

Clinical Context: Why Cost Access Matters for Methimazole

Graves disease, the most common cause of hyperthyroidism, affects roughly 1 in 200 Americans 6. Left untreated, hyperthyroidism increases the risk of atrial fibrillation, osteoporosis, and thyroid storm. A life-threatening event.

The ATA's 2016 guidelines recommend methimazole as the first-line antithyroid drug for nearly all non-pregnant adults with Graves disease 5. The standard initial dose is 10 to 30 mg daily, adjusted based on thyroid function tests every 4 to 8 weeks. Most patients transition to a maintenance dose of 5 to 10 mg daily within 3 to 6 months. Total treatment duration typically spans 12 to 18 months for a first trial of antithyroid drug therapy, with remission rates of 40% to 60% after a full course 2.

For Idaho patients, the total out-of-pocket cost of a complete 18-month methimazole course at generic cash prices comes to roughly $270. That compares favorably with the alternatives. Radioactive iodine ablation costs $1,000 to $5,000 depending on the facility and insurance, and thyroidectomy ranges from $10,000 to $25,000 before insurance adjustments 7. Methimazole also preserves the option of remission without permanent thyroid destruction, a consideration many patients value.

Monitoring costs add to the total. TSH and free T4 panels cost $30 to $100 per draw without insurance, with roughly 6 to 10 blood draws needed during an 18-month course. Idaho patients using telehealth platforms can sometimes access bundled lab-plus-visit pricing that reduces per-encounter costs compared to traditional office visits plus separate lab billing.

Comparing Idaho to Neighboring States

Idaho's average $15 monthly cash price for generic methimazole is consistent with other Mountain West states. Oregon averages $14 to $16, Utah $13 to $17, and Montana $16 to $20 based on 2026 pharmacy survey data. Wyoming tends to run slightly higher at $18 to $22, reflecting its smaller pharmacy market.

The key differentiator for Idaho is the Medicaid gap. Oregon Medicaid covers methimazole. Washington Medicaid covers it. Utah Medicaid covers it. Idaho stands as an outlier among neighboring states in excluding methimazole from its Medicaid formulary. For the approximately 380,000 Idahoans enrolled in Medicaid, this means paying the $15 cash price out of pocket or pursuing prior authorization, a process that neighboring state residents do not face 8.

Idaho's 503A compounding pharmacy access is comparable to neighboring states. All Mountain West states permit 503A compounding under the federal framework. Idaho does not impose additional restrictions that would limit compounded methimazole availability relative to Oregon, Washington, or Utah.